BCL2 and non-small cell lung carcinoma: Previous studies have shown that benzimidazole anthelmintics potentiate the cytotoxicity of BH3 mimetic ABT-263 (a BCL2/BCL2L1 inhibitor) on non-small cell lung cancer [20].